We are Sangtech Lab.
A Taiwanese filter manufacturer with its own material science R&D, supplying the next generation of whole blood solutions.
01Who we are
Sangtech Lab makes filters that know the difference. Our in-house R&D team engineers filter media to be selective: to keep what matters and take out what doesn’t. We go looking for the needs the market hasn’t met, and build the products that meet them.
CellNet™ PR is where it starts: selective filtration for whole blood, supplied to the companies that build blood collection sets and the blood centers that use them. We research in Taipei and manufacture in our ISO 13485 plant in Yilan. CellNet™ PR is the first and only commercial whole blood inline leukoreduction filter in the world manufactured without organic solvents or process wastewater.
- Founded
- 2014
- Taipei
- Headquarters
- Taipei
- Beitou District
- Manufacturing
- Yilan
- ISO 13485 site
- Experience
- 35 years
- In filtration, since 1991
- Awards
- 2
- Edison · R&D 100, 2026
02Mission and vision
Mission
We re-engineer proven materials and partner with our customers to meet the needs the market hasn’t.
Vision
We envision a future where the materials the world already trusts can do far more, for people, for industry and for the planet.
03What we do
- Develop
Proprietary media
Designed in-house for what each application needs to capture.
- Modify
Patented SCF modification
Clean and solvent-free, without the limits of chemical coatings.
- Deliver
Finished products
Built and released from our ISO 13485 plant in Yilan.
Every product we deliver shapes the next media we develop.
04What we make
CellNet™ PR
Leukocyte and platelet removal filters for whole blood.
PR 250 · PR 500View the productNew media, new applications
New products from our own pipeline, and from partner programs built around yours. Either way, we develop the media and deliver the product.
R&D · TaipeiHave a challenge? Let’s talk.
05Our history
- 2014
Sangtech Lab Inc. is founded in Taipei.
- 2016
Research begins on supercritical fluid (SCF) media modification and CellNet™.
- 2022
Production plant built in Yilan.
- 2022
Sangtech’s supercritical fluid process for leukocyte reduction filters named an R&D 100 Awards finalist.
- 2025
CellNet™ commercialized, made at the Yilan plant under ISO 13485.
- 2026
CellNet™ media recognized with an Edison Award (Silver) and an R&D 100 Award.
- 2026
First CellNet™ PR red cell storage results presented at ISBT.
06Locations
Taipei
3F, No. 3, Alley 16, Lane 120, Lide Road, Beitou Dist., Taipei City, Taiwan
View on map: TaipeiYilan
No. 7, Yike North Road, Jianye Village, Yilan City, Yilan County 260, Taiwan
View on map: YilanMaps: Ministry of the Interior, Taiwan (open data).
07Quality and recognition
- ISO 13485Quality management system for medical devicesRequest certificate: ISO 13485
- ISO 10993-5Biocompatibility: in vitro cytotoxicityRequest report: ISO 10993-5
-
Edison Awards 2026Silver · Energy and Climate Resiliency -
R&D 100 Awards 2026Winner · Process and Prototyping